Additional Details
-
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCH Research InstituteNaples FL. 34102View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Intercoastal Medical GroupSarasota FL. 34239View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of Kansas Medical CenterKansas City KS. 66160View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of New Mexico Health Sciences CenterAlbuquerque NM. 87131View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University Medical Center - New OrleansNew Orleans LA. 70112View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Northwell HealthNew Hyde Park NY. 11042View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Summit HealthBend OR. 97701View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Legacy Research InstitutePortland OR. 97210View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
AnMed HealthAnderson SC. 29621View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Associates of Richmond, Inc.Richmond VA. 23230View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Mayo Clinic- ScottsdaleScottsdale AZ. 85259View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
University of California - San FranciscoSan Francisco CA. 94143View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
UT Southwestern Medical CenterDallas TX. 75390View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Cleveland ClinicCleveland OH. 44195View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Montefiore Medical CenterThe Bronx NY. 10467View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Institut universitaire de cardiologie et de pneumologie de Québec-Université LavalQuébec QC. G1V4G5View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
The Pennsylvania State UniversityHershey PA. 17033View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
University of Utah HealthSalt Lake City UT. 84108View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Loyola University Medical CenterMaywood IL. 60153View Details